Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Effects of activity interruptions by pain on pattern of activity performance - an experimental investigation.

Gatzounis R, Schrooten MGS, Crombez G, Vlaeyen JWS.

Scand J Pain. 2018 Jan 26;18(1):109-119. doi: 10.1515/sjpain-2017-0098.

PMID:
29794288
2.

Cognitive behavioral therapy for irritable bowel syndrome: the effects on state and trait anxiety and the autonomic nervous system during induced rectal distensions - An uncontrolled trial.

Edebol-Carlman H, Schrooten M, Ljótsson B, Boersma K, Linton S, Brummer RJ.

Scand J Pain. 2018 Jan 26;18(1):81-91. doi: 10.1515/sjpain-2017-0153.

PMID:
29794287
3.

A Time-Varying Connectivity Analysis from Distributed EEG Sources: A Simulation Study.

Ghumare EG, Schrooten M, Vandenberghe R, Dupont P.

Brain Topogr. 2018 Jan 27. doi: 10.1007/s10548-018-0621-3. [Epub ahead of print]

PMID:
29374816
4.

Anterior interosseous mononeuropathy associated with HEV infection.

Swinnen B, Boeynaems S, Schrooten M, Saegeman V, Claeys KG, Van Damme P.

Neurol Neuroimmunol Neuroinflamm. 2017 Dec 22;5(2):e429. doi: 10.1212/NXI.0000000000000429. eCollection 2018 Mar. No abstract available.

5.

Forgetting to remember? Prospective memory within the context of pain.

Gatzounis R, Schrooten MGS, Crombez G, Vlaeyen JWS.

Eur J Pain. 2018 Mar;22(3):614-625. doi: 10.1002/ejp.1152. Epub 2017 Dec 11.

PMID:
29226495
6.

Activity interruptions by pain impair activity resumption, but not more than activity interruptions by other stimuli: an experimental investigation.

Gatzounis R, Schrooten MGS, Crombez G, Vlaeyen JWS.

Pain. 2018 Feb;159(2):351-358. doi: 10.1097/j.pain.0000000000001079.

PMID:
28968344
7.

Attentional control and the competition between nonpain goals and the threat of pain.

Karsdorp PA, Schrooten MGS, Geenen R.

Eur J Pain. 2018 Jan;22(1):181-190. doi: 10.1002/ejp.1114. Epub 2017 Sep 26.

PMID:
28949062
8.

Taking a break in response to pain. An experimental investigation of the effects of interruptions by pain on subsequent activity resumption.

Gatzounis R, Schrooten MGS, Crombez G, Vancleef LMG, Vlaeyen JWS.

Scand J Pain. 2017 Jul;16:52-60. doi: 10.1016/j.sjpain.2017.02.008. Epub 2017 Mar 22.

PMID:
28850412
9.

Effects of validating communication on recall during a pain-task in healthy participants.

Carstens JKP, Boersma K, Schrooten MGS, Linton SJ.

Scand J Pain. 2017 Oct;17:118-125. doi: 10.1016/j.sjpain.2017.07.003. Epub 2017 Aug 12.

PMID:
28850364
10.

Prognostic value of clinical and electrodiagnostic parameters at time of diagnosis in patients with amyotrophic lateral sclerosis.

Reniers W, Schrooten M, Claeys KG, Tilkin P, D'Hondt A, Van Reijen D, Couwelier G, Lamaire N, Robberecht W, Fieuws S, Van Damme P.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Aug;18(5-6):341-350. doi: 10.1080/21678421.2017.1288254. Epub 2017 Feb 15.

PMID:
28631957
11.

Electrocorticography of Spatial Shifting and Attentional Selection in Human Superior Parietal Cortex.

Schrooten M, Ghumare EG, Seynaeve L, Theys T, Dupont P, Van Paesschen W, Vandenberghe R.

Front Hum Neurosci. 2017 May 11;11:240. doi: 10.3389/fnhum.2017.00240. eCollection 2017.

12.

Changing pain expectations: the role of social context and communication.

Schrooten MGS, Linton SJ.

Pain. 2017 Jul;158(7):1185-1186. doi: 10.1097/j.pain.0000000000000922. No abstract available.

PMID:
28426551
13.

Face-to-Face Cognitive-Behavioral Therapy for Irritable Bowel Syndrome: The Effects on Gastrointestinal and Psychiatric Symptoms.

Edebol-Carlman H, Ljótsson B, Linton SJ, Boersma K, Schrooten M, Repsilber D, Brummer RJ.

Gastroenterol Res Pract. 2017;2017:8915872. doi: 10.1155/2017/8915872. Epub 2017 Jan 22.

14.

Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus.

Vandenbussche N, Cassiman C, Schrooten M, Gille B, Bossuyt X, Vincent T, Van Damme P, Poesen K.

Neurol Neuroimmunol Neuroinflamm. 2017 Feb 3;4(2):e329. doi: 10.1212/NXI.0000000000000329. eCollection 2017 Mar. No abstract available.

15.

Minimal EEG montage with high yield for the detection of status epilepticus in the setting of postanoxic brain damage.

Vanherpe P, Schrooten M.

Acta Neurol Belg. 2017 Mar;117(1):145-152. doi: 10.1007/s13760-016-0663-9. Epub 2016 Jul 1.

PMID:
27369692
16.

Exposure-based cognitive behavioral therapy for irritable bowel syndrome. A single-case experimental design across 13 subjects.

Boersma K, Ljótsson B, Edebol-Carlman H, Schrooten M, Linton SJ, Brummer RJ.

Cogn Behav Ther. 2016 Nov;45(6):415-30. doi: 10.1080/16506073.2016.1194455. Epub 2016 Jun 10.

PMID:
27285475
17.

Awaji criteria improves the diagnostic sensitivity in amyotrophic lateral sclerosis: A systematic review using individual patient data.

Geevasinga N, Loy CT, Menon P, de Carvalho M, Swash M, Schrooten M, Van Damme P, Gawel M, Sonoo M, Higashihara M, Noto Y, Kuwabara S, Kiernan MC, Macaskill P, Vucic S.

Clin Neurophysiol. 2016 Jul;127(7):2684-91. doi: 10.1016/j.clinph.2016.04.005. Epub 2016 Apr 16.

PMID:
27212114
18.

Quality Control of Motor Unit Number Index (MUNIX) Measurements in 6 Muscles in a Single-Subject "Round-Robin" Setup.

Neuwirth C, Burkhardt C, Alix J, Castro J, de Carvalho M, Gawel M, Goedee S, Grosskreutz J, Lenglet T, Moglia C, Omer T, Schrooten M, Weber M.

PLoS One. 2016 May 2;11(5):e0153948. doi: 10.1371/journal.pone.0153948. eCollection 2016.

19.

Voxel-based lesion-symptom mapping of stroke lesions underlying somatosensory deficits.

Meyer S, Kessner SS, Cheng B, Bönstrup M, Schulz R, Hummel FC, De Bruyn N, Peeters A, Van Pesch V, Duprez T, Sunaert S, Schrooten M, Feys H, Gerloff C, Thomalla G, Thijs V, Verheyden G.

Neuroimage Clin. 2015 Dec 11;10:257-66. doi: 10.1016/j.nicl.2015.12.005. eCollection 2016.

20.

Comparison of different Kalman filter approaches in deriving time varying connectivity from EEG data.

Ghumare E, Schrooten M, Vandenberghe R, Dupont P.

Conf Proc IEEE Eng Med Biol Soc. 2015 Aug;2015:2199-202. doi: 10.1109/EMBC.2015.7318827.

PMID:
26736727
21.

Genetic Creutzfeldt-Jakob disease mimicking chronic inflammatory demyelinating polyneuropathy.

Weckhuysen D, Schrooten M, Demaerel P, Van Broeckhoven C, Tousseyn T, Kovacs GG, Van Damme P.

Neurol Neuroimmunol Neuroinflamm. 2015 Oct 29;2(6):e173. doi: 10.1212/NXI.0000000000000173. eCollection 2015 Dec. No abstract available.

22.

Sub-optimal presentation of painful facial expressions enhances readiness for action and pain perception following electrocutaneous stimulation.

Khatibi A, Schrooten M, Bosmans K, Volders S, Vlaeyen JW, Van den Bussche E.

Front Psychol. 2015 Jul 7;6:913. doi: 10.3389/fpsyg.2015.00913. eCollection 2015.

23.

Acute ataxic neuropathy associated with hepatitis E virus infection.

Bruffaerts R, Yuki N, Damme PV, Moortele MV, Wautier M, Lagrou K, Nevens F, Schrooten M.

Muscle Nerve. 2015 Sep;52(3):464-5. doi: 10.1002/mus.24676. Epub 2015 May 14. No abstract available.

PMID:
25847012
24.

Attention allocation to ambiguous health/somatic threat cues.

Schrooten MG, Vancleef L, Vlaeyen JW.

Eur J Pain. 2015 Aug;19(7):1002-11. doi: 10.1002/ejp.628. Epub 2014 Nov 25.

PMID:
25421151
25.

An experimental examination of catastrophizing-related interpretation bias for ambiguous facial expressions of pain using an incidental learning task.

Khatibi A, Schrooten MG, Vancleef LM, Vlaeyen JW.

Front Psychol. 2014 Sep 17;5:1002. doi: 10.3389/fpsyg.2014.01002. eCollection 2014.

26.

When pain meets … pain-related choice behavior and pain perception in different goal conflict situations.

Schrooten MGS, Wiech K, Vlaeyen JWS.

J Pain. 2014 Nov;15(11):1166-1178. doi: 10.1016/j.jpain.2014.08.011. Epub 2014 Sep 16.

PMID:
25218553
27.

Attention effects on vicarious modulation of nociception and pain.

Khatibi A, Vachon-Presseau E, Schrooten M, Vlaeyen J, Rainville P.

Pain. 2014 Oct;155(10):2033-9. doi: 10.1016/j.pain.2014.07.005. Epub 2014 Jul 9.

PMID:
25016217
28.

Interrupted by pain: an anatomy of pain-contingent activity interruptions.

Gatzounis R, Schrooten MG, Crombez G, Vlaeyen JW.

Pain. 2014 Jul;155(7):1192-5. doi: 10.1016/j.pain.2014.03.017. Epub 2014 Mar 29. Review. No abstract available.

PMID:
24686254
29.

Pain catastrophizing moderates the effects of pain-contingent task interruptions.

Schrooten MG, Karsdorp PA, Vlaeyen JW.

Eur J Pain. 2013 Aug;17(7):1082-92. doi: 10.1002/j.1532-2149.2012.00276.x. Epub 2013 Jan 16.

PMID:
23322650
30.

Supranuclear gaze palsy in glycine receptor antibody-positive progressive encephalomyelitis with rigidity and myoclonus.

Peeters E, Vanacker P, Woodhall M, Vincent A, Schrooten M, Vandenberghe W.

Mov Disord. 2012 Dec;27(14):1830-2. doi: 10.1002/mds.25239. Epub 2012 Nov 5. No abstract available.

PMID:
23129530
31.

A venlafaxine and mirtazapine-induced serotonin syndrome confirmed by de- and re-challenge.

Decoutere L, De Winter S, Vander Weyden L, Spriet I, Schrooten M, Tournoy J, Fagard K.

Int J Clin Pharm. 2012 Oct;34(5):686-8. doi: 10.1007/s11096-012-9666-7. Epub 2012 Jul 3. Erratum in: Int J Clin Pharm. 2012 Oct;34(5):689.

PMID:
22752315
32.

Pain catastrophizing, threat, and the informational value of mood: task persistence during a painful finger pressing task.

Karsdorp PA, Ranson S, Schrooten MG, Vlaeyen JW.

Pain. 2012 Jul;153(7):1410-7. doi: 10.1016/j.pain.2012.02.026. Epub 2012 Apr 28.

PMID:
22542915
33.

Nonpain goal pursuit inhibits attentional bias to pain.

Schrooten MG, Van Damme S, Crombez G, Peters ML, Vogt J, Vlaeyen JW.

Pain. 2012 Jun;153(6):1180-6. doi: 10.1016/j.pain.2012.01.025. Epub 2012 Mar 10.

PMID:
22409943
34.

Psychological interventions for chronic pain: reviewed within the context of goal pursuit.

Schrooten MG, Vlaeyen JW, Morley S.

Pain Manag. 2012 Mar;2(2):141-50. doi: 10.2217/pmt.12.2.

PMID:
24645815
35.

Operant learning theory in pain and chronic pain rehabilitation.

Gatzounis R, Schrooten MG, Crombez G, Vlaeyen JW.

Curr Pain Headache Rep. 2012 Apr;16(2):117-26. doi: 10.1007/s11916-012-0247-1. Review.

PMID:
22261987
36.

Chronometry of word and picture identification: common and modality-specific effects.

Van Doren L, Schrooten M, Adamczuk K, Dupont P, Vandenberghe R.

Neuroimage. 2012 Feb 15;59(4):3701-12. doi: 10.1016/j.neuroimage.2011.11.068. Epub 2011 Dec 4.

PMID:
22155326
37.

The PACE trial in chronic fatigue syndrome.

Vlaeyen JW, Karsdorp P, Gatzounis R, Ranson S, Schrooten M.

Lancet. 2011 May 28;377(9780):1834; author reply 1834-5. doi: 10.1016/S0140-6736(11)60682-X. Epub 2011 May 16. No abstract available.

PMID:
21592559
38.

Does medical specialty influence the treatment of asymptomatic carotid stenosis? a Belgian multidisciplinary survey.

Schrooten M, Fourneau I, Thijs V, Verhamme P, Nevelsteen A.

J Cardiovasc Surg (Torino). 2011 Apr;52(2):153-7.

PMID:
21460764
39.

Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: a prospective study.

Schrooten M, Smetcoren C, Robberecht W, Van Damme P.

Ann Neurol. 2011 Jul;70(1):79-83. doi: 10.1002/ana.22380. Epub 2011 Mar 17.

PMID:
21437935
40.

Progressive encephalomyelitis with rigidity and myoclonus: resolution after thymectomy.

Clerinx K, Breban T, Schrooten M, Leite MI, Vincent A, Verschakelen J, Tousseyn T, Vandenberghe W.

Neurology. 2011 Jan 18;76(3):303-4. doi: 10.1212/WNL.0b013e318207b008. No abstract available.

PMID:
21242500
41.

Mutations in PEX10 are a cause of autosomal recessive ataxia.

Régal L, Ebberink MS, Goemans N, Wanders RJ, De Meirleir L, Jaeken J, Schrooten M, Van Coster R, Waterham HR.

Ann Neurol. 2010 Aug;68(2):259-63. doi: 10.1002/ana.22035. Review.

PMID:
20695019
42.

Microbleeds and the risk of recurrent stroke.

Thijs V, Lemmens R, Schoofs C, Görner A, Van Damme P, Schrooten M, Demaerel P.

Stroke. 2010 Sep;41(9):2005-9. doi: 10.1161/STROKEAHA.110.588020. Epub 2010 Jul 22.

43.

Becoming active again? Further thoughts on goal pursuit in chronic pain.

Schrooten MG, Vlaeyen JW.

Pain. 2010 Jun;149(3):422-3. doi: 10.1016/j.pain.2010.02.038. Epub 2010 Mar 12. No abstract available.

PMID:
20227180
44.

Inducing impulsivity leads high and low restrained eaters into overeating, whereas current dieters stick to their diet.

Guerrieri R, Nederkoorn C, Schrooten M, Martijn C, Jansen A.

Appetite. 2009 Aug;53(1):93-100. doi: 10.1016/j.appet.2009.05.013. Epub 2009 May 23.

PMID:
19467278
45.

Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale.

Lansberg MG, Schrooten M, Bluhmki E, Thijs VN, Saver JL.

Stroke. 2009 Jun;40(6):2079-84. doi: 10.1161/STROKEAHA.108.540708. Epub 2009 Apr 16. Review.

46.

Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study.

Hermans G, Schrooten M, Van Damme P, Berends N, Bouckaert B, De Vooght W, Robberecht W, Van den Berghe G.

Crit Care. 2009;13(1):R5. doi: 10.1186/cc7694. Epub 2009 Jan 24.

47.

Normalization of 14-3-3 in CJD.

Schrooten M, De Vooght W, Weckhuysen S, Van Paesschen W, Van Damme P.

Acta Neurol Belg. 2008 Jun;108(2):64-6.

PMID:
18795599
48.

is leukoaraiosis on CT an accurate surrogate marker for the presence of microbleeds in acute stroke patients?

Görner A, Lemmens R, Schrooten M, Thijs V.

J Neurol. 2007 Mar;254(3):284-9. Epub 2007 Mar 7.

PMID:
17345053
49.

Association of apolipoprotein E epsilon2 with white matter disease but not with microbleeds.

Lemmens R, Görner A, Schrooten M, Thijs V.

Stroke. 2007 Apr;38(4):1185-8. Epub 2007 Feb 22.

50.

A Simon effect for threat-related stimulus content.

Schrooten MG, Smulders FT.

J Behav Ther Exp Psychiatry. 2007 Jun;38(2):121-32. Epub 2006 Nov 15.

PMID:
17109814

Supplemental Content

Loading ...
Support Center